Integrated Biopharma Stock Technical Analysis
INBPDelisted Stock | USD 0.33 0.00 0.00% |
As of the 2nd of December, Integrated Biopharma retains the Market Risk Adjusted Performance of (0.39), risk adjusted performance of (0.02), and Standard Deviation of 4.05. Integrated Biopharma technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We have analyzed thirteen technical drivers for Integrated Biopharma, which can be compared to its competitors.
Integrated Biopharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Integrated, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to IntegratedIntegrated |
Integrated Biopharma technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Integrated Biopharma Technical Analysis
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
Integrated Biopharma Trend Analysis
Use this graph to draw trend lines for Integrated Biopharma. You can use it to identify possible trend reversals for Integrated Biopharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Integrated Biopharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Integrated Biopharma Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Integrated Biopharma applied against its price change over selected period. The best fit line has a slop of 0.0006 , which may suggest that Integrated Biopharma market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.01, which is the sum of squared deviations for the predicted Integrated Biopharma price change compared to its average price change.About Integrated Biopharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Integrated Biopharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Integrated Biopharma based on its technical analysis. In general, a bottom-up approach, as applied to this otc stock, focuses on Integrated Biopharma price pattern first instead of the macroeconomic environment surrounding Integrated Biopharma. By analyzing Integrated Biopharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Integrated Biopharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Integrated Biopharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
Integrated Biopharma December 2, 2024 Technical Indicators
Most technical analysis of Integrated help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Integrated from various momentum indicators to cycle indicators. When you analyze Integrated charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | (0.02) | |||
Market Risk Adjusted Performance | (0.39) | |||
Mean Deviation | 1.52 | |||
Coefficient Of Variation | (3,056) | |||
Standard Deviation | 4.05 | |||
Variance | 16.44 | |||
Information Ratio | (0.07) | |||
Jensen Alpha | (0.19) | |||
Total Risk Alpha | (0.82) | |||
Treynor Ratio | (0.40) | |||
Maximum Drawdown | 34.54 | |||
Value At Risk | (5.56) | |||
Potential Upside | 3.13 | |||
Skewness | 0.5004 | |||
Kurtosis | 11.85 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Integrated Biopharma information on this page should be used as a complementary analysis to other Integrated Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Integrated OTC Stock
If you are still planning to invest in Integrated Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Integrated Biopharma's history and understand the potential risks before investing.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |